IP Library Granted Patent US 7,671,196
Granted Patent B2
US 7,671,196 · App. 11/491,590 · Granted Mar 2, 2010

Diazepinoquinolines, synthesis thereof, and intermediates thereto

Assignee: Wyeth LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,671,196
App. No.
11/491,590
Granted
Mar 2, 2010
Kind
B2
Abstract

The present invention relates to methods for synthesizing compounds useful as 5HT 2C agonists or partial agonists, derivatives thereof, and to intermediates thereto.

Claims (42)

1. A method for preparing a compound of formula II:

or a pharmaceutically acceptable salt thereof, wherein:

n is 1;

R 1 and R 2 are each independently halogen, —CN, phenyl, —R, —OR, —C 1-6 perfluoroalkyl, or —OC 1-6 perfluoroalkyl;

each R is independently hydrogen or a C 1-6 alkyl group; and

R 7 is hydrogen or C 1-6 alkyl,

comprising the steps of:

(a) providing a compound of formula E

 wherein:

R 1 and R 2 are each independently halogen, —CN, phenyl, —R, —OR, —C 1-6 perfluoroalkyl, or —OC 1-6 perfluoroalkyl; and

each R is independently hydrogen or a C 1-6 alkyl group,

(b) treating said compound of formula E with a chiral agent to form a compound of formula D-1:

wherein:

R 1 and R 2 are each independently halogen, —CN, phenyl, —R, —OR, —C 1-6 perfluoroalkyl, or —OC 1-6 perfluoroalkyl;

each R is independently hydrogen or a C 1-6 alkyl group; and

X is a chiral agent,

(c) obtaining a compound of formula D by suitable physical means:

 wherein:

R 1 and R 2 are each independently halogen, —CN, phenyl, —R, —OR, —C 1-6 perfluoroalkyl, or —OC 1-6 perfluoroalkyl;

each R is independently hydrogen or a C 1-6 alkyl group; and

X is a chiral agent,

(d) treating said compound of formula D with a suitable base to provide a compound of formula C:

 wherein:

R 1 and R 2 are each independently halogen, —CN, phenyl, —R, —OR, —C 1-6 perfluoroalkyl, or —OC 1-6 perfluoroalkyl; and

each R is independently hydrogen or a C 1-6 alkyl group,

(e) alkylating said compound of formula C to form a compound of formula B:

 wherein:

n is 1;

R 1 and R 2 are each independently halogen, —CN, phenyl, —R, —OR, —C 1-6 perfluoroalkyl, or —OC 1-6 perfluoroalkyl;

each R is independently hydrogen or a C 1-6 alkyl group; and

PG 2 is a suitable amino protecting group,

(f) deprotecting said compound of formula B to form a compound of formula A

 wherein:

n is 1;

R 1 and R 2 are each independently halogen, —CN, phenyl, —R, —OR, —C 1-6 perfluoroalkyl, or —OC 1-6 perfluoroalkyl; and

each R is independently hydrogen or a C 1-6 alkyl group, and

(g) reacting said compound of formula A with formaldehyde, or an equivalent thereof, to form a compound of formula II.

2. The method according to claim 1 , wherein each n is 1 and R 1 and R 2 are both hydrogen.

3. The method according to claim 1 , wherein said formaldehyde is aqueous formaldehyde.

4. The method according to claim 1 , wherein the alkylation at step (e) is achieved by reacting said compound of formula C with

in the presence of a suitable acid to form a compound of formula B:

wherein n is 1 and PG 2 is acetyl.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2006
From: MEGATI, SREENIVASULU; CHAN, ANITA WAI-YIN; FEIGELSON, GREGG B.
To: WYETH
Reel/Frame 018370/0449 →
Continuity (2)
Provisional Application 6070250900 · Jul 26, 2005
Related Publication 20070027142A1 · Feb 1, 2007